Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 7, 2012, Pages 947-951

  Singla, Dinender K ^a   Rocher, Crystal ^a   Singla, Reetu ^a   Singal, Pawan K ^a,b   Parthasarathy, Sampath ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Atherosclerosis; IL 10; Macrophages; Monocytes

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOGENIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE MONOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; MACROPHAGE; PRIORITY JOURNAL;

BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELLS, CULTURED; CHEMOKINE CCL2; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGES; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863651284     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y2012-102     Document Type: Article

References (11)

1. Amthor, H., Christ, B., Rashid-Doubell, F., Kemp, C.F., Lang, E., and Patel, K. 2002. Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev. Biol. 243(1): 115-127. doi:10.1006/dbio.2001.0555. PMID: 11846481.
2. Boon, M.R., van der Horst, G., van der Pluijm, G., Tamsma, J.T., Smit, J.W.A., and Rensen, P.C.N. 2011. Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency. Cytokine Growth Factor Rev. 22(4): 221-229. doi:10.1016/j.cytogfr.2011.08.001. PMID:21924665.
3. Bosukonda, D., Shih, M.S., Sampath, K.T., and Vukicevic, S. 2000. Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys. Kidney Int. 58(5): 1902-1911. PMID:11044210.
4. El Hadri, K., Mahmood, D.F.D., Couchie, D., Jguirim-Souissi, I., Genze, F., Diderot, V., et al. 2012. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32(6): 1445-1452. doi:10.1161/ATVBAHA.112.249334. PMID:22516068.
5. Lovren, F., Pan, Y., Quan, A., Szmitko, P.E., Singh, K.K., Shukla, P.C., et al. 2010. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am. J. Physiol. Heart Circ. Physiol. 299(3): H656-H663. doi:10.1152/ajpheart. 00115.2010. PMID:20622108.
6. Moore, K.J., and Tabas, I. 2011. Macrophages in the pathogenesis of atherosclerosis. Cell, 145(3): 341-355. doi:10.1016/j.cell.2011.04. 005. PMID:21529710.
7. Santanam, N., Song, M., Rong, R., Murphy, A.A., and Parthasarathy, S. 2002. Atherosclerosis, oxidation and endometriosis. Free Radic. Res. 36(12): 1315-1321. doi:10.1080/1071576021000049908. PMID:12607823.
8. Selvarajan, K., Moldovan, L., Chandrakala, A.N., Litvinov, D., and Parthasarathy, S. 2011. Peritoneal macrophages are distinct from monocytes and adherent macrophages. Atherosclerosis, 219(2): 475-483. doi:10.1016/j.atherosclerosis.2011.09.014. PMID:21982410.
9. Singla, D.K., and McDonald, D.E. 2007. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am. J. Physiol. Heart Circ. Physiol. 293(3): H1590-H1595. doi:10.1152/ ajpheart.00431.2007. PMID:17545477.
10. Wang, S., Chen, Q., Simon, T.C., Strebeck, F., Chaudhary, L., Morrissey, J., et al. 2003. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int. 63(6): 2037-2049. doi:10.1046/j.1523-1755.2003.00035.x. PMID:12753291.
11. Wolfs, I.M., Donners, M.M., and de Winther, M.P. 2011. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation. Thromb. Haemost. 106(5): 763-771. doi:10.1160/TH11-05-0320. PMID: 21947328.